Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
BSX.PRA was delisted on the 31st of May, 2023.
54 hedge funds and large institutions have $989M invested in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in 2022 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 12 increasing their positions, 17 reducing their positions, and 7 closing their positions.
29% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 7
4% more funds holding
Funds holding: 52 → 54 (+2)
3% less capital invested
Capital invested by funds: $1.02B → $989M (-$29.4M)
29% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 17
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VOYA Investment Management
Atlanta,
Georgia
|
+$286M |
| 2 |
CAM
Camden Asset Management
Los Angeles,
California
|
+$4.23M |
| 3 |
P8IP
Pier 88 Investment Partners
San Francisco,
California
|
+$2.9M |
| 4 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$2.81M |
| 5 |
State Street
Boston,
Massachusetts
|
+$2.65M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Allianz Asset Management
Munich,
Germany
|
-$254M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$28.3M |
| 3 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$14.7M |
| 4 |
Calamos Advisors
Naperville,
Illinois
|
-$9.9M |
| 5 |
OA
Oxbow Advisors
Austin,
Texas
|
-$5.09M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Osaic Holdings
Scottsdale,
Arizona
| $79K | – | – | – |
|
|
MA
52
MUFG Americas
New York
| $30K | -$21.2K | -200 | -40% |
|
53
Royal Bank of Canada
Toronto,
Ontario, Canada
| $5K | – | – | – |
|
|
PTC
54
Private Trust Company
Cleveland,
Ohio
| $2K | +$2.22K | +21 | New |
|
|
PA
55
Parallel Advisors
San Francisco,
California
| $1K | – | – | – |
|
|
56
Allianz Asset Management
Munich,
Germany
| – | -$254M | -2,501,010 | Closed |
|
|
57
Mirae Asset Global Investments
Seoul,
South Korea
| – | -$14.7M | -144,446 | Closed |
|
|
OA
58
Oxbow Advisors
Austin,
Texas
| – | -$5.09M | -50,193 | Closed |
|
|
FSA
59
Financial Sense Advisors
San Diego,
California
| – | -$5.03M | -49,555 | Closed |
|
|
KCPG
60
Kavar Capital Partners Group
Leawood,
Kansas
| – | -$629K | -6,200 | Closed |
|
|
PM
61
Phraction Management
Colchester,
Connecticut
| – | -$336K | -3,310 | Closed |
|
|
HDIM
62
Hanson & Doremus Investment Management
Burlington,
Vermont
| – | -$14K | -134 | Closed |
|
BSX.PRA Hedge Fund Activity: Q3 2022 in Review
54 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) for Q3 2022, worth a combined $989M — down 2.9% from $1.02B a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new BSX.PRA positions and 7 closed out — a net gain of 2 holders — while 12 added to existing stakes and 17 trimmed.
The largest buyer was VOYA Investment Management, opening a new position worth an estimated $286M. The largest seller was Allianz Asset Management, exiting entirely with an estimated $254M sold.
- 54 institutional investors held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) as of Q3 2022, up from 52 in Q2 2022.
- Funds reported $989M of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A stock for Q3 2022, down 2.9% quarter-over-quarter.
- 9 funds opened new Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A positions in Q3 2022 and 7 closed out, a net change of +2 holders.
- The largest Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A buyer in Q3 2022 was VOYA Investment Management, an estimated $286M added.
- The largest Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A seller in Q3 2022 was Allianz Asset Management, an estimated $254M sold.
Based on aggregated 13F filings for Q3 2022.